Litcius/Paper detail

Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes

Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Mohammad Javad Hosseinzadeh‐Attar, Abolhasan Shakeri, Mohammad Asghari Jafarabadi, Neda Roshanravan, Nazila Farrin, Mohammad Naemi, Milad Hasankhani

2020Pharmacological Research58 citationsDOI

Topics & Concepts

Internal medicineEndocrinologyFatty liverMedicineTriglycerideLipid profileHypertriglyceridemiaSteatosisBody mass indexPlaceboCholesterolPathologyDiseaseAlternative medicineFatty Acid Research and HealthLiver Disease Diagnosis and TreatmentAdipose Tissue and Metabolism
Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes | Litcius